Wednesday, 21 August 2013

Feds Focus on Drowsy Driving Risks from Prescription Drugs

The number of motorists who drive in an impaired state after taking medications is high across the country. However, it has been a challenge for the federal administration to deal with this very pressing highway safety issue, because many of these motorists are driving under the influence of prescription drugs, like sleep medication.
However, Orlando car accident lawyers now see signs that the federal administration is taking these challenges very seriously. For instance, the Food and Drug Administration recently decided to reject a petition filed by pharmaceutical giant Merck for a new sleep drug. Tests showed that the sleep drug affected people’s driving abilities the next day.
Earlier this year, the agency also warned persons who took common anti-allergy and cough and cold medications like Benadryl, to avoid driving the next day, saying that many of the sedative effects of such medications are likely to carry on into the next day as well. In January, the Food and Drug Administration required manufacturers of Ambien and other sedatives to cut down dosage requirements for women by half.
The Food andDrug Administration also intends to more closely examine all sleep medications that are currently available in the market, and plans to ask companies to conduct more extensive driving tests using these drugs. The main   concern has been the person’s driving abilities, not just a few hours after he takes medication, but the morning after the person has taken the medication. The effect of many sleep medications can continue into the next morning, leaving the person feeling very drowsy and increasing his risk of being involved in an accident.
While everyone agrees on the impairing effects of many sleep medications and other medications, there are no one-shot solutions.   Medications affect different people in different ways, creating a challenge in restricting driving under the influence of these drugs.

No comments:

Post a Comment